Consistent with previous studies in metastatic CRC [21], both TMB‐H and MSI‐H samples were significantly more abundant in the RAS/BRAF‐altered cohort, an effect that is driven by BRAF class 1 mutated samples. This evidence concerns the gene BRAF and colorectal carcinoma.